Open-uri20171025-4-1us7yl1_thumb

Freedom Ahn

Writer

Freedom Ahn

Writer | Journalist | Ghostwriter | Marketer | Editor
Business | Technology

Open-uri20180711-4-1pqzgng_profile

Robots are the anwer to lowering food costs

It’s the year 2020, the Earth’s population has reached 10 billion, and food is becoming more scarce and more expensive. How do we meet the need? This is a question agriculturalists, politicians, and those in food production have asked for decades. Food waste reduction through legal means and adjusted consumer habits is a high priority across the globe but the worry remains.
Open-uri20180319-4-1bmqb7w_profile

The Human Endocannabinoid System

Our bodies naturally create compounds called endocannabinoids. And when we use cannabis, the cannabinoids present in the plant—including, but not limited to THC—engage a large network of cell receptors in our bodies that are part of something called the endocannabinoid system (ECS). Parts of the Endocannabinoid System The ECS is comprised of three main parts; receptors found on the surface of the cells; naturally occurring molecules that activate cannabinoid receptors called endocannabinoids; and the enzymes that help break down the endocannabinoids after they’ve been used. Cannabinoid Receptors Cannabinoid receptors rest on the surface of cells and are constantly receiving information about the conditions surrounding the cell. They pass on that information to the cell’s interior, triggering an appropriate cellular-level response. These receptors are the messengers that tell your body how to respond to certain situations (and when to cease activity). This helps our bodies maintain something called ‘homeostasis,’ which is another way of describing our body in optimal balance or a stable internal environment. An ECS in balance is believed to play a role in the establishment of overall health and prevention of certain conditions When there is a disruption in our ECS, it can cause an imbalance pushing our body out of homeostasis. That imbalance, referred to as “Clinical Endocannabinoid Deficiency,” is believed to be a contributing factor for conditions such as irritable bowel syndrome and fibromyalgia.
Hempster Link to Story

About

Freedom Ahn

Canadian-born Freedom Ahn (Chevalier) is a journalist, writer, ghostwriter, marketer, and editor. (She's also a best-selling novelist and an awarding-winning short-fiction author and songwriter.)
---
Her first assignment following graduation was covering political & civil unrest in the Middle East. Since then, she has written about politics, science, environment, business, & finance, and worked with people from a diverse cross-section of society helping them tell their story. She has worked with Emmy-, Grammy-, Oscar-, Tony-, and Pulitzer-prize winners, in addition to New York Times Bestselling Authors.

Her writing has appeared in global publications including The Independent (UK), Huffington Post (USA), The Telegraph (UK), The Chicago Sun-Times, The Los Angeles Times, The Jerusalem Post, and more.

She has worked with multinational organizations such as Aprio (HA+W), Manulife, Morgan Stanley, ADP, Deloitte, The Toronto Stock Exchange, BDO, & ADP, as well as dynamic startups & small business enterprises including Six-Figure Wealth, Targeted Blockchain Technologies, and ZipBooks.

She holds multiple marketing certifications.

Contact information can be found at freedomahn.com

--
American Society of Journalists & Authors (USA)
Society of Professional Journalists (USA)
Writer's Guild of America - East
Dramatists Guild (USA)

Open-uri20171025-4-1us7yl1_profile_large

www.freedomahn.com

Skills

  • Blockchain
  • Cryptocurrency
  • Thought Leadership
  • Book Writing
  • Ghostwriting
  • Features Writing
  • Corporate Communications
  • Reporting
  • Japanese Culture
  • Fintech
  • Technology
  • Finance
  • Business
  • Journalism